Intrinsiqq
Guardian Pharmacy Services Inc. logo

Guardian Pharmacy Services Inc. Quality Score

GRDN

Compare
Quality71

Growth remains strong (avg 85/100), but valuation is pulling the composite down (avg 40/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
40/100
34.4x

Above 30x, priced for sustained outperformance

Cash Flow Multiple
40/100
34.5x

Above 30x, cash flow yield is thin

Revenue Growth
70/100
8.9%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
100/100
100.8%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
0/100
21.0%

Heavy dilution above 5%

Margin Trend
100/100
+11.6pp

Expanded 3+pp, strong improvement

Capital Structure
100/100
-$84M

Net cash position, no leverage concern

2024
$5.00M
$37.0M
2025
$66.0M
$45.0M
TTM
$120M
$36.0M
CashDebt
Return on Capital
100/100
22.8%

Above 20%, exceptional capital efficiency

Customize WeightsPremiumUpgrade

Guardian Pharmacy Services (GRDN) quality: score, margins and returns

Guardian Pharmacy Services (GRDN) scores 71/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 6.5% operating margins and 22.8% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Guardian Pharmacy Services (GRDN) a high-quality business?+

Guardian Pharmacy Services scores 71 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 6.5% operating margin and a 22.8% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Guardian Pharmacy Services's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from GRDN's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Guardian Pharmacy Services scores well and where it falls behind.

What is Guardian Pharmacy Services's return on invested capital (ROIC)?+

Guardian Pharmacy Services earns about 22.8% on its invested capital, which is exceptional. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to GRDN's margins and growth on this scorecard to judge durability.

How profitable is Guardian Pharmacy Services?+

Guardian Pharmacy Services runs an operating margin of about 6.5% and a net margin of about 5.1%. Revenue has grown at roughly 17.9% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 5 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 7 Nov 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Retail-Drug Stores and Proprietary Stores · Pick stocks to compare with GRDN

CompareIntrinsic value
PETSPetMed Express Inc.
$0.85-7.60%13
NEGGNewegg Commerce, Inc.
$7.99-3.62%24
BZUNBaozun Inc.
$2.84-7.04%60
FLWS1-800-Flowers.com Inc.
$1.87-11.37%14
SPHSuburban Propane Partners LP
$16.52-2.02%39
RVLVRevolve Group, Inc.
$18.37-2.55%47
GCTGigaCloud Technology Inc
$57.82-4.33%85
SFIXStitch Fix Inc.
$2.59-3.90%39

Held by ETFs

GRDN is in 37 US ETFs. The largest of them, with GRDN's weight in each:

Spot a number that looks wrong? Check it in GRDN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GRDN

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.